Search results
Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 5 hours agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share ...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 3 days agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
Proactive Investors· 5 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after...
What Direction Does Merck & Co Inc (NYSE: MRK) Analysts Think The Company Will Take? – Stocks...
Stocks Register· 6 days agoThe trading price of Merck & Co Inc (NYSE:MRK) remained unchanged on Tuesday, April 23, closing at $126.88. The company’s P/E ratio in ...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 4 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 5 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
MRK Stock Sees Surge of Approximately 1.30% in Last Five Days – Knox Daily
Knox Daily· 5 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Merck & Co Inc shares ...
Merck Earnings Preview: Strong quarter expectations on the back of core products' growth
Seeking Alpha· 6 days agoMerck (NYSE:MRK) is scheduled to announce Q1 earnings results on Thursday, April 25th, before market...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 16 hours agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 5 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...